Clinical Trials

ALPS

Description

Status: Open to Enrollment

Start Date: Jan 03 2011

End Date: Jun 30 2013

Open to women who are delivering a baby between 34 weeks and 36 weeks 5 days.

Looking to see if medication for fetal lung maturity, which is routinely given to women delivering before 34 weeks, should be given in this late pre-term period.  Consists of 2 doses of medication, chart review and 2 follow up phone calls.  Compensation available.

Call for eligibility criteria (801) 585-5499


Principal Investigators

Michael Varner, M.D.

Contact Information

Name: Amber
Phone: 801-585-5499
Email: kerri.sowles@hsc.utah.edu

Please Note:

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician. If you do not have a primary care physician, we can help you find a University of Utah doctor or clinic location to meet your health care needs.

Although the studies described on this Web site may have potential benefits as described, the University of Utah and its physicians and affiliated hospitals cannot and do not guarantee or promise that you will receive any benefits from participating in a study.

The information posted on this site is consistent with the research reviewed and approved by the University of Utah Institutional Review Board (IRB). However, the IRB has not reviewed all material posted on this site. Contact the IRB if you have questions regarding your rights as a research participant. Also contact the IRB if you have questions, complaint, or concerns which you do not feel you can discuss with the investigator. The University of Utah IRB may be reached by phone at (801) 581-3655 or by e-mail at irb@hsc.utah.edu.